Vor to participate in two upcoming investor conferences

Cambridge, mass., jan. 04, 2022 (globe newswire) -- vor biopharma (nasdaq: vor), a clinical-stage cell and genome engineering company, today announced that members of its senior management team will be participating in two upcoming virtual investor conferences:
VOR Ratings Summary
VOR Quant Ranking